Brain-Computer Interfaces: The Internet of Us

article image

Neural interfaces are bringing a new understanding of disease processes, and a way to intervene with devices that speak the language of the brain. The field is burgeoning with good ideas, many still in the realm of research, but there are some focused and relatively near-term medical opportunities.

In July, Elon Musk was in the news when his brain-computer interface (BCI) start-up Neuralink Corp. raised a $205 million Series C round. That’s a whopping total of $363 million raised to date for the six-year-old company but not surprising, because like all of Musk’s projects, Neuralink is an ambitious undertaking that requires lots of capital. The start-up is creating an entire nanoscale platform—surgical nanorobotics, inductive chargers, large-scale manufacturing and all—for recording electrical signals from the brain and delivering electrical therapies to restore sensory functions lost through disease or injury. That sounds like deep brain stimulation, and it is, but what’s different now is the ability to implant thousands of tiny electrodes so that we can analyze the firing patterns of neurons with greater accuracy and insight than ever before.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: